Trial Profile
A safety and efficacy study of abciximab in patients with acute limb ischemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Coronary artery restenosis; Ischaemia
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2016 New trial record